Australia's Opyl eyes best day in more than 16 months on deal with Bristol-Myers Squibb

Pathkey.AI

18/01/2023 01:02

** Shares of healthcare tech co Opyl Ltd  OPL.AX  rise as
much as 31% to A$0.038, post their biggest intraday pct gain
since Aug. 30, 2021
    ** Co says it will provide clinical trial recruitment
services to U.S. biopharmaceutical firm Bristol-Myers Squibb
 BMY.N  
    ** Adds its digital health research recruitment platform has
obtained "approved and preferred supplier status" with BMY,
which will help it win more contracts 
    ** Stock hits highest level since Dec. 2, 2022
    ** OPL stock flat YTD 
 (Reporting by Harshita Swaminathan)
 ((Harshita.Swaminathan@thomsonreuters.com))